Clinical Trials Logo

Clinical Trial Summary

Study design: Double blind, randomized, placebo controlled study. Participants will be randomly assigned either to the intervention group or the placebo control group. Randomization for the two study groups will be made in a ratio of 1:1. The primary objective of the study is to assess the effect of 6-12 months treatment with nutritional supplementation standardized formula, in short and lean female adolescents on weight Standard Deviation Score (SDS) and height SDS The Secondary Objectives of the study are to assess the effect of 6-12 months treatment with nutritional supplementation standardized formula, in short and lean female adolescents on BMI SDS, growth velocity, time to puberty, quality of life and self-esteem The study will continue for 6 months of intervention versus active placebo, with additional optional 6 months (an extension period), in which participants at both groups, the intervention and the placebo, will be offered to continue their participation in the study with the study supplement. All analyses of the effect's on primary and secondary outcome measurements will take into account the consumption rate of the study formula/placebo


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02397200
Study type Interventional
Source Rabin Medical Center
Contact Moshe Phillip, Prof
Phone 972-3-9253747
Email mosheph@clalit.org.il
Status Recruiting
Phase N/A
Start date June 2015
Completion date August 2024

See also
  Status Clinical Trial Phase
Completed NCT01158352 - Study to Evaluate the Effect of Short Treatment With Nutritional Supplementation Standardized Innovative Formula, on Growth and Weight Gain in Short and Lean Prepubertal Children N/A
Withdrawn NCT03323177 - Long Term Effects of Nutritional Supplementation on Final Height N/A
Completed NCT02389803 - Evaluating the Effect of Nutritional Supplementation on Growth of Short and Lean Adolescents Boys N/A